Closing Biological Age Gap Could Reduce Stroke Risk and Support Brain Health

Biological age gap and brain health: study signals potential for stroke risk reduction

• The report summarizes findings presented at the American Academy of Neurology’s 78th Annual Meeting from an abstract that has not yet undergone peer-reviewed publication.
• The investigation examined health data from more than 258,000 individuals, evaluating 18 health-related biomarkers (including cholesterol profiles and red blood cell measures) alongside brain imaging to estimate each participant’s biological age.
• A subset of roughly 6,000 participants underwent a follow-up assessment, allowing recalculation of biological age and enabling analysis of changes over time.

A positive gap indicates faster-than-chronological aging, while a negative gap suggests relatively slower aging.

• Chronological age is defined by calendar years since birth, whereas biological age reflects physiological functioning, inferred from routinely obtained blood tests and other health markers.
• The biological age gap is the difference between biological age and chronological age.
• The study focused on whether shifts in this gap over time relate to later brain outcomes, particularly stroke risk and markers of brain tissue integrity.

Specifically, a 23% lower risk of stroke was observed among those who improved their gap.

• At baseline, participants averaged 56 years chronologically and 54 years biologically; six years later, averages were 62 and 58, respectively.
• Improvement in the biological age gap over the study period—meaning biological age movements closer to or younger than chronological age—was associated with a reduction in stroke risk during subsequent follow-up.
• The results emphasize change over time rather than a single measurement, suggesting that trajectories of biological aging may offer actionable insights for brain health.

White matter hyperintensities reflect tissue damage that can be linked to memory issues and cognitive decline.

• In addition to stroke risk, participants with an improving biological age gap exhibited lower volumes of white matter hyperintensities on MRI.
• Quantitatively, the total burden of such white matter damage decreased by 13% per standard deviation of improvement in the biological age gap, indicating a meaningful neural correlate aligned with the behavioral outcome.

• The authors frame the study as addressing whether biological aging can be manipulated to influence brain health and reduce adverse neurological outcomes, including cognitive decline, stroke, and dementia.
• The emphasis lies on change in biological aging over time, not merely a cross-sectional snapshot of younger biological age being protective.
• The findings are preliminary, given the abstract status and lack of peer-reviewed publication at the time of reporting.

• The results are based on an abstract presented at a conference and have not yet been published in a peer-reviewed journal, which constrains full appraisal of methodology, statistical nuance, and generalizability.
• The summary does not provide granular numerical outcomes beyond the reported 23% stroke risk reduction and 13% reduction per standard deviation in white matter hyperintensity burden, nor details about confounding adjustments or population subgroups.
• It remains unclear whether specific lifestyle or medical factors driving changes in the biological age gap were directly characterized or controlled for within the analysis.

• If replicated and clarified in peer-reviewed work, these findings could shape research into strategies for modulating biological aging as a pathway to preserving brain health and reducing stroke risk.
• Further inquiry is needed to identify which modifiable factors most effectively influence the biological age gap and its longitudinal trajectory, and how these relate to neuroimaging markers and clinical outcomes.
• Additional studies should assess the consistency of these associations across diverse populations, different follow-up intervals, and varied imaging modalities.

• The current report documents a potential link between improvements in the biological age gap over time and lower stroke risk, alongside attenuated white matter pathology, in a large observational dataset.
• Because the evidence originates from an abstract, conclusions should be considered provisional pending peer-reviewed publication and replication in independent cohorts.

• Specific intervention details, such as lifestyle modifications or pharmacologic approaches used by participants, are not delineated in the provided content.
• Precise numerical effect sizes beyond the highlighted 23% stroke risk reduction and 13% white matter burden change were not disclosed.